GoodwinGoodwin

Expertise

  1. Antitrust & Competition
  2. Appellate and Supreme Court Litigation
  3. Business & Commercial Litigation
  4. Complex Litigation & Dispute Resolution
  5. Data, Privacy & Cybersecurity
  6. Employment
  7. Environmental
  8. ERISA Litigation
  9. Financial Services Litigation
  10. Government Contracts & Grants
  11. Government Investigations, Enforcement & White Collar Defense
  12. Intellectual Property Litigation
  13. Investment Management Litigation
  14. Life Sciences & Technology Arbitrations
  15. Litigation
  16. Products Litigation & Counseling
  17. Securities Litigation & SEC Enforcement
  18. Trade Secrets, Employee Mobility & Non-Competes

  1. Antitrust & Competition
  2. Banking
  3. Data, Privacy & Cybersecurity
  4. Digital Currency & Blockchain
  5. Employment
  6. Environmental
  7. ERISA & Executive Compensation
  8. ESG & Impact
  9. Life Sciences Regulatory & Compliance
  10. Financial Restructuring
  11. Fintech
  12. Global Trade
  13. Government Contracts & Grants
  14. Insurtech
  15. Investment Management
  16. Late Stage Drug Development
  17. Private Investment Funds
  18. Risk Management & Insurance
  19. Tax
  20. Tax-Exempt Organizations
  21. Trusts & Estates
  22. Proptech
  23. Public Company Advisory Practice

  1. Asset Management Transactions
  2. Banking
  3. Buyouts & Acquisitions
  4. Capital Markets
  5. Corporate Social Responsibility Law & Policy
  6. Data, Privacy & Cybersecurity
  7. Debt Finance
  8. Derivatives
  9. Digital Currency & Blockchain
  10. Employment
  11. Environmental
  12. ERISA & Executive Compensation
  13. ESG & Impact
  14. Financial Restructuring
  15. Government Contracts & Grants
  16. Growth Equity
  17. Intellectual Property
  18. Mergers & Acquisitions
  19. New Company Formation
  20. Private Investment Funds
  21. REITs & Real Estate M&A
  22. Search Funds
  23. Secondaries
  24. Shareholder Activism & Takeover Defense
  25. Special Purpose Acquisition Companies (SPACs)
  26. Tax
  27. Tax-Exempt Organizations
  28. Trusts & Estates
  29. Venture Capital

A

  1. Acute Care Hospitals and Health Systems
  2. Antitrust & Competition
  3. Antitrust Services for Life Sciences Companies
  4. Appellate and Supreme Court Litigation
  5. Artificial Intelligence & Machine Learning
  6. Asset Management Transactions

B

  1. Banking
  2. Brokers, Exchanges, and Trading
  3. Business & Commercial Litigation
  4. Buyouts & Acquisitions

C

  1. Cannabis
  2. Capital Markets
  3. Class Actions
  4. Climate Tech
  5. Clinical Trials Services
  6. Complex Litigation & Dispute Resolution
  7. Consumer Financial Services
  8. Consumer Financial Services Enforcement & Government Investigations
  9. Consumer Financial Services Litigation
  10. Copyrights
  11. Corporate Social Responsibility Law & Policy
  12. Crowdfunding

D

  1. Data, Privacy & Cybersecurity
  2. Debt Capital Markets
  3. Debt Finance
  4. Derivatives
  5. Digital Currency & Blockchain
  6. Digital Health
  7. Direct Listings
  8. Distressed Real Estate

E

  1. Employment
  2. Environmental
  3. ERISA & Executive Compensation
  4. ERISA Litigation
  5. ESG & Impact

F

  1. Faculty Practice Plans
  2. Fair & Responsible Lending
  3. False Claims Act
  4. FDA Litigation
  5. Financial Restructuring
  6. Financial Services
  7. Financial Services Litigation
  8. Fintech
  9. Food & Healthy Living
  10. Foreign Corrupt Practices Act
  11. For-Profit and Nonprofit Healthcare Joint Ventures
  12. Fund Finance

G

  1. Gaming & Gambling
  2. Global Trade
  3. Government Contracts & Grants
  4. Government Investigations, Enforcement & White Collar Defense
  5. Group Purchasing Organizations, Buying Cooperatives and the Supply Chain
  6. Growth Equity

H

  1. Hatch-Waxman, Biologics and Biosimilars Litigation
  2. Healthcare
  3. Healthcare Disputes & Investigations
  4. Healthcare Private Equity
  5. Healthcare Regulatory and Compliance
  6. Hedge Funds
  7. Higher Education
  8. Hospitality & Leisure

I

  1. Industrial Technology & Advanced Manufacturing
  2. Insurance
  3. Insurtech
  4. Intellectual Property
  5. Intellectual Property Litigation
  6. Investment Management
  7. Investment Management Litigation
  8. ITC 337 Proceedings

L

  1. Late Stage Drug Development
  2. Leasing
  3. Life Sciences
  4. Life Sciences & Technology Arbitrations
  5. Life Sciences Asia
  6. Life Sciences Collaborations & Licensing
  7. Life Sciences Emerging Companies
  8. Life Sciences Europe
  9. Life Sciences IPOs & Capital Markets
  10. Life Sciences M&A
  11. Life Sciences Patent Prosecution & Counseling
  12. Life Sciences Regulatory & Compliance
  13. Life Sciences Securities Litigation & Healthcare Fraud
  14. Litigation
  15. Long-Term Care Organizations

M

  1. Medtech
  2. Mergers & Acquisitions
  3. Metaverse
  4. Mortgage Banking

N

  1. New Company Formation
  2. Nonprofit and For-Profit Hospitals and Health Systems

O

  1. Open Source Software
  2. Operational Real Estate
  3. Opinions & Counseling

P

  1. Patent Litigation
  2. Patent Prosecution & Counseling
  3. Patent Trial & Appeal Board
  4. Pharmacy
  5. Physician Practice Management
  6. Post-Acute Care Transactions
  7. Private Equity
  8. Private Equity Asia
  9. Private Equity France
  10. Private Equity Germany
  11. Private Equity UK
  12. Private Investment Funds
  13. Private Investment Litigation
  14. Private Market Liquidity
  15. Products Litigation & Counseling
  16. Proptech
  17. Public Company Advisory Practice

R

  1. Real Estate
  2. Real Estate Acquisitions & Dispositions
  3. Real Estate Design & Construction
  4. Real Estate Development & Permitting
  5. Real Estate Dispute Resolution
  6. Real Estate Finance & Restructuring
  7. Real Estate Investment Funds
  8. Real Estate Joint Ventures
  9. Real Estate Tax
  10. REITs & Real Estate M&A
  11. Risk Management & Insurance

S

  1. Search Funds
  2. Secondaries
  3. Securities Litigation & SEC Enforcement
  4. Securitization & Derivatives
  5. Shareholder Activism & Takeover Defense
  6. Special Purpose Acquisition Companies (SPACs)
  7. Specialty Pharmacy and 340B
  8. Sports
  9. State Attorneys General
  10. Strategic Technology Transactions and Licensing

T

  1. Tax
  2. Tax-Exempt Organizations
  3. Technology
  4. Technology Europe
  5. Technology M&A
  6. Trade Secrets, Employee Mobility & Non-Competes
  7. Trademarks
  8. Trusts & Estates

V

  1. Venture Capital
  2. Venture Capital & Private Equity Funds

W

  1. Women's Health & Wellness
Subscribe For Updates
Copyright © 2024 Goodwin Procter LLP